Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
about
Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.Clinical utility of etanercept in the treatment of arthritides in children and adolescents.Cost of biologics in the treatment of juvenile idiopathic arthritis: a factor not to be overlooked.Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
P2860
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@en
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@nl
type
label
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@en
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@nl
prefLabel
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@en
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@nl
P2093
P2860
P1476
Clinical remission in juvenile idiopathic arthritis after termination of etanercept.
@en
P2093
Edyta Olesińska
Jacek Postępski
Katarzyna Kobusińska
Violetta Osińska
P2860
P2888
P304
P356
10.1007/S00296-012-2468-3
P577
2012-07-21T00:00:00Z